Leflunomide for the Treatment of Rheumatoid Arthritis in Clinical Practice: Incidence and Severity of Hepatotoxicity

ISSN： 0114-5916

Source： Drug Safety, Vol.27, Iss.5, 2004-01, pp. : 345-352

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leflunomide for the treatment of rheumatoid arthritis

By Miceli-Richard Corinne Dougados Maxime

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. : 987-997

Informa Healthcare

Access to resources Recommend Favorite

Leflunomide: a novel DMARD for the treatment of rheumatoid arthritis

By Alldred A. Emery P.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 1, 2001-01 ,pp. : 125-137

Informa Healthcare

Access to resources Recommend Favorite

Short-Term Efficacy and Safety of Leflunomide in the Treatment of Active Rheumatoid Arthritis in Everyday Clinical Use: Open-Label, Prospective Study

By Nguyen M.

Clinical Drug Investigation, Vol. 24, Iss. 2, 2004-01 ,pp. : 103-112

Adis International

Access to resources Recommend Favorite

Association of DHODH haplotype variants and response to leflunomide treatment in rheumatoid arthritis

By O’Doherty Catherine Schnabl Matthew Spargo Llewellyn Cleland Leslie G James Michael Proudman Susanna M Wiese Michael D

Pharmacogenomics, Vol. 13, Iss. 12, 2012-09 ,pp. : 1427-1434

Future Medicine

Access to resources Recommend Favorite

Safety evaluation of leflunomide in rheumatoid arthritis

By I Keen Helen

Expert Opinion on Drug Safety, Vol. 12, Iss. 4, 2013-07 ,pp. : 581-588

Informa Healthcare

Access to resources Recommend Favorite